Targeting CD22 with the monoclonal antibody epratuzumab...

Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling

Giltiay, Natalia V., Shu, Geraldine L., Shock, Anthony, Clark, Edward A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-017-1284-2
Date:
December, 2017
File:
PDF, 1.90 MB
english, 2017
Conversion to is in progress
Conversion to is failed